Canandaigua National Bank & Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,434
| Closed | -$259K | – | 342 |
|
|
2024
Q2 | $259K | Sell |
2,434
-681
| -22% | -$68.4K | 0.03% | 268 |
|
|
2024
Q1 | $301K | Sell |
3,115
-467
| -13% | -$47.9K | 0.04% | 218 |
|
|
2023
Q4 | $362K | Sell |
3,582
-1,682
| -32% | -$162K | 0.06% | 189 |
|
|
2023
Q3 | $536K | Sell |
5,264
-252
| -5% | -$25.6K | 0.09% | 165 |
|
|
2023
Q2 | $557K | Sell |
5,516
-60
| -1% | -$6K | 0.09% | 165 |
|
|
2023
Q1 | $513K | Buy |
+5,576
| New | +$487K | 0.09% | 168 |
|
|
2020
Q1 | $562K | Buy |
6,820
+171
| +3% | +$15.3K | 0.12% | 154 |
|
|
2019
Q4 | $630K | Sell |
6,649
-230
| -3% | -$20.6K | 0.11% | 157 |
|
|
2019
Q3 | $598K | Sell |
6,879
-75
| -1% | -$6.73K | 0.11% | 159 |
|
|
2019
Q2 | $635K | Sell |
6,954
-649
| -9% | -$54.9K | 0.12% | 151 |
|
|
2019
Q1 | $655K | Buy |
7,603
+1,160
| +18% | +$93.1K | 0.13% | 142 |
|
|
2018
Q4 | $495K | Sell |
6,443
-809
| -11% | -$63K | 0.1% | 155 |
|
|
2018
Q3 | $560K | Buy |
7,252
+279
| +4% | +$20.6K | 0.1% | 160 |
|
|
2018
Q2 | $472K | Sell |
6,973
-61
| -0.9% | -$4.21K | 0.09% | 166 |
|
|
2018
Q1 | $510K | Buy |
7,034
+3,828
| +119% | +$291K | 0.07% | 208 |
|
|
2017
Q4 | $241K | Hold |
3,206
| – | – | 0.04% | 222 |
|
|
2017
Q3 | $247K | Sell |
3,206
-415
| -11% | -$31.3K | 0.05% | 219 |
|
|
2017
Q2 | $271K | Sell |
3,621
-795
| -18% | -$56.3K | 0.06% | 207 |
|
|
2017
Q1 | $293K | Buy |
4,416
+487
| +12% | +$32.5K | 0.09% | 162 |
|
|
2016
Q4 | $256K | Hold |
3,929
| – | – | 0.08% | 162 |
|
|
2016
Q3 | $278K | Sell |
3,929
-141
| -3% | -$10.3K | 0.08% | 162 |
|
|
2016
Q2 | $301K | Sell |
4,070
-19
| -0.5% | -$1.31K | 0.09% | 153 |
|
|
2016
Q1 | $265K | Sell |
4,089
-1,065
| -21% | -$72.5K | 0.08% | 161 |
|
|
2015
Q4 | $397K | Buy |
5,154
+117
| +2% | +$9.29K | 0.12% | 138 |
|
|
2015
Q3 | $415K | Buy |
5,037
+12
| +0.2% | +$1.07K | 0.13% | 136 |
|
|
2015
Q2 | $443K | Sell |
5,025
-55
| -1% | -$5.05K | 0.13% | 137 |
|
|
2015
Q1 | $449K | Sell |
5,080
-17
| -0.3% | -$1.51K | 0.13% | 134 |
|
|
2014
Q4 | $423K | Buy |
5,097
+335
| +7% | +$27.8K | 0.13% | 135 |
|
|
2014
Q3 | $402K | Buy |
4,762
+28
| +0.6% | +$2.27K | 0.13% | 132 |
|
|
2014
Q2 | $384K | Hold |
4,734
| – | – | 0.13% | 134 |
|
|
2014
Q1 | $361K | Sell |
4,734
-22
| -0.5% | -$1.6K | 0.12% | 131 |
|
|
2013
Q4 | $343K | Sell |
4,756
-1,323
| -22% | -$92K | 0.12% | 129 |
|
|
2013
Q3 | $418K | Sell |
6,079
-364
| -6% | -$24.1K | 0.16% | 119 |
|
|
2013
Q2 | $408K | Buy |
+6,443
| New | +$419K | 0.16% | 117 |
|
Other funds holding NVS
Canandaigua National Bank & Trust's NVS Position: Q3 2024 in Review
Canandaigua National Bank & Trust sold out of Novartis (NVS) in Q3 2024, closing a stake of 2,434 shares — an estimated $259K sold.
Canandaigua National Bank & Trust first reported a position in NVS in Q2 2013 and held it in 34 quarters. The position peaked at $655K in Q1 2019. 1,312 funds tracked by Wall St. Rank hold NVS as of Q3 2024.
- Canandaigua National Bank & Trust reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
- Canandaigua National Bank & Trust sold 2,434 Novartis shares in Q3 2024, an estimated $259K.
- Canandaigua National Bank & Trust first reported a position in Novartis in Q2 2013 and held it in 34 quarters.
- Canandaigua National Bank & Trust's Novartis position peaked at $655K in Q1 2019.
- 1,312 funds tracked by Wall St. Rank held Novartis as of Q3 2024.
Based on Canandaigua National Bank & Trust's 13F filing for Q3 2024, filed 3 Oct 2024.